BioCentury
ARTICLE | Company News

Arcaris, Deltagen deal

July 30, 2001 7:00 AM UTC

DGEN will acquire functional proteomics company Arcaris for 765,000 DGEN shares valued at $6.7 million based on DGEN's Friday close at $8.70, plus $450,000 in cash. Arcaris shareholders are eligible t...